News
-
Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
-
Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
-
Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
-
For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
-
Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
-
Funding Circle Plc: POS-Transaction in Own Shares
-
LIGHTON announces highly successful IPO on Euronext Growth Paris.
-
2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
-
Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
-
Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
-
MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
-
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
-
Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo